DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
KEY PRODUCTS
Reset all filters
01 1Dr. Reddy's Laboratories
Reset all filters
01 1FINASTERIDE USP (FORM III)
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16010
Submission : 2002-06-11
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is FINASTERIDE USP (FORM III), with a corresponding US DMF Number 16010.
Remarkably, this DMF maintains an Active status since its submission on June 11, 2002, highlighting commitment to regulatory compliance.